Open-label extension data show fasedienol appears well tolerated and steadily improves social anxiety scores with as-needed intranasal use, as Vistagen plans FDA discussions.
|Articles|May 22, 2020
Challenges of Grounding Ourselves in the Breath
Author(s)John J. Miller, MD
After so many weeks of sheltering in place, watching the news, and not going to restaurants or other public places due to the pandemic, how do we re-engage and re-integrate slowly and maintain calm?
Advertisement
After so many weeks of sheltering in place, watching the news, and not going to restaurants or other public places due to the pandemic, how do we re-engage and re-integrate slowly and maintain calm? Dr John Miller addresses these issues.
Dr Miller is Medical Director,
Advertisement
Related to this article
Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
Single-dose DT120 ODT delivers rapid, sustained anxiety relief in phase 3 GAD trial, supporting FDA breakthrough path and NDA plans.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Top 7 Atypical Psychedelics: A Brief Clinical Guide
2
Positive Topline Phase 3 Study Results: Lumateperone for Manic Episodes in Bipolar I Disorder
3
New Analyses of HLP003 for the Adjunctive Treatment of MDD
4
Positive Phase 1b Results Demonstrate Clinical Proof-of-Concept for ALKS 7290 in Adults With ADHD
5